China Resources Medical Holdings Company Limited (FRA:1PH)
Germany
· Delayed Price · Currency is EUR 0.358
0.00 (0.00%)
At close: Dec 5, 2025
FRA:1PH Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 475 | 642 | 724 | 896 | 678 | 911 | Upgrade
|
| Market Cap Growth | -22.61% | -11.34% | -19.24% | 32.11% | -25.49% | 35.80% | Upgrade
|
| Enterprise Value | 608 | 928 | 643 | 859 | 682 | 733 | Upgrade
|
| Last Close Price | 0.36 | 0.46 | 0.51 | 0.64 | 0.47 | 0.62 | Upgrade
|
| PE Ratio | 8.48 | 8.57 | 22.02 | 24.85 | 11.73 | 23.45 | Upgrade
|
| PS Ratio | 0.43 | 0.49 | 0.56 | 0.84 | 1.10 | 2.64 | Upgrade
|
| PB Ratio | 0.51 | 0.65 | 0.81 | 0.62 | 0.72 | 1.15 | Upgrade
|
| P/TBV Ratio | 1.41 | 1.86 | 2.62 | 1.16 | 1.20 | 2.21 | Upgrade
|
| P/FCF Ratio | 4.85 | 6.86 | 8.01 | 16.63 | 9.57 | 16.75 | Upgrade
|
| P/OCF Ratio | 2.95 | 3.82 | 4.75 | 7.65 | 6.90 | 11.30 | Upgrade
|
| EV/Sales Ratio | 0.53 | 0.71 | 0.50 | 0.80 | 1.11 | 2.13 | Upgrade
|
| EV/EBITDA Ratio | 4.46 | 5.34 | 3.57 | 7.17 | 9.34 | 15.70 | Upgrade
|
| EV/EBIT Ratio | 9.63 | 9.32 | 5.91 | 14.09 | 13.41 | 21.04 | Upgrade
|
| EV/FCF Ratio | 6.21 | 9.93 | 7.12 | 15.94 | 9.63 | 13.48 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.21 | 0.33 | 0.23 | 0.25 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 1.00 | 1.16 | 1.58 | 2.57 | 3.14 | 2.47 | Upgrade
|
| Debt / FCF Ratio | 1.24 | 2.26 | 3.26 | 6.05 | 3.38 | 2.23 | Upgrade
|
| Asset Turnover | 0.69 | 0.73 | 0.64 | 0.56 | 0.46 | 0.33 | Upgrade
|
| Inventory Turnover | 27.55 | 26.65 | 24.50 | 23.87 | 21.49 | 20.71 | Upgrade
|
| Quick Ratio | 0.62 | 0.59 | 0.55 | 1.20 | 1.02 | 1.66 | Upgrade
|
| Current Ratio | 0.74 | 0.72 | 0.66 | 1.32 | 1.14 | 1.88 | Upgrade
|
| Return on Equity (ROE) | 7.02% | 9.26% | 3.71% | 3.75% | 6.46% | 5.13% | Upgrade
|
| Return on Assets (ROA) | 1.92% | 3.49% | 3.39% | 1.99% | 2.37% | 2.07% | Upgrade
|
| Return on Capital (ROIC) | 2.85% | 5.11% | 4.76% | 2.60% | 2.89% | 2.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 8.50% | 10.10% | 3.50% | 5.20% | 4.10% | Upgrade
|
| Earnings Yield | 11.79% | 11.67% | 4.54% | 4.02% | 8.53% | 4.26% | Upgrade
|
| FCF Yield | 20.61% | 14.57% | 12.49% | 6.01% | 10.45% | 5.97% | Upgrade
|
| Dividend Yield | 4.46% | 3.77% | 1.51% | 0.70% | 2.88% | 1.50% | Upgrade
|
| Payout Ratio | 29.51% | 24.59% | 16.44% | 48.75% | 21.79% | 37.11% | Upgrade
|
| Buyback Yield / Dilution | - | - | -0.18% | 0.14% | -0.21% | -0.50% | Upgrade
|
| Total Shareholder Return | 4.46% | 3.77% | 1.33% | 0.84% | 2.67% | 1.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.